TIGRX
Price
$16.64
Change
+$0.16 (+0.97%)
Updated
Oct 20 closing price
Net Assets
7.1B
VSTSX
Price
$317.21
Change
+$3.54 (+1.13%)
Updated
Oct 20 closing price
Net Assets
2.02T
Interact to see
Advertisement

TIGRX vs VSTSX

Header iconTIGRX vs VSTSX Comparison
Open Charts TIGRX vs VSTSXBanner chart's image
Nuveen Core Equity R6
Price$16.64
Change+$0.16 (+0.97%)
VolumeN/A
Net Assets7.1B
Vanguard Total Stock Mkt Idx Instl Sel
Price$317.21
Change+$3.54 (+1.13%)
VolumeN/A
Net Assets2.02T
TIGRX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
TIGRX vs. VSTSX commentary
Oct 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TIGRX is a Buy and VSTSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.02T vs. TIGRX (7.1B). VSTSX pays higher dividends than TIGRX: VSTSX (1.15) vs TIGRX (0.88). TIGRX was incepted earlier than VSTSX: TIGRX (26 years) vs VSTSX (9 years). TIGRX (0.40) is less costly to investors than VSTSX (0.01). TIGRX is a more actively managed with annual turnover of: 25.00 vs. VSTSX (2.00). TIGRX has a lower initial minimum investment than VSTSX: TIGRX (1000000) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 13.82 vs. TIGRX (-0.80). VSTSX return over 5 years is better than : 85.01 vs. TIGRX (7.05).
TIGRXVSTSXTIGRX / VSTSX
Total Expense Ratio0.400.014,000%
Annual Report Gross Expense Ratio0.400.014,000%
Fund Existence26 years9 years-
Gain YTD10.05213.02977%
Front LoadN/AN/A-
Min. Initial Investment100000050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets7.1B2.02T0%
Annual Yield % from dividends0.881.1576%
Returns for 1 year-0.8013.82-6%
Returns for 3 years29.5776.1639%
Returns for 5 years7.0585.018%
Returns for 10 years43.55N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INDP3.700.27
+7.87%
Indaptus Therapeutics Inc
APPN28.150.36
+1.30%
Appian Corp
IONS73.090.02
+0.03%
Ionis Pharmaceuticals
LGO1.29-0.03
-2.27%
Largo
FDMT9.84-0.25
-2.48%
4D Molecular Therapeutics